Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

NCT00322985

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Cancer Care Manitoba Winnipeg, Manitoba, Canada
  • Queen Elizabeth II, Health Services Centre Halifax, Nova Scotia, Canada
View Trial Details
Completed

S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

NCT00107380

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Piedmont Hospital Atlanta, Georgia, United States
View all 78 locations
View Trial Details
Completed

Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma

NCT01523860

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Divisione di Ematologia Ospedale SS. Antonio e Biagio Alessandria, Italy
  • SOS Ematologia Ospedale C. Massaia Asti, Italy
  • Ematologia con Trapianto, Università di Bari Bari, Italy
  • Medicina Interna, Ospedale degli Infermi Biella, Italy
View all 37 locations
View Trial Details
Completed

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01426373

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mark Rubin Beverly Hills, California, United States
  • Mitchel Goldman La Jolla, California, United States
  • Jeffrey Klein San Juan Capistrano, California, United States
  • Ava Shamban Santa Monica, California, United States
View all 18 locations
View Trial Details
Completed

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653

Conditions
Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
Locations
  • Sandoz Investigational Site Innsbruck, Austria
  • Sandoz Investigational Site Kufstein, Austria
  • Sandoz Investigational Site Leoben, Austria
  • Sandoz Investigational Site Deurne, Belgium
View all 117 locations
View Trial Details

Related conditions